As Director of Health Science and Technology, Dr. Charles A. Gardner manages the Foundation’s investments in innovation to catalyze and accelerate the development of higher-efficacy smoking cessation products and services, and to ensure that options to quit and reduce harm are accessible in low- and middle-income countries.
Dr. Gardner has over two decades of experience creating and managing international health R&D programs and partnerships in Africa, Asia, Latin America and the Middle East. He has served as the Program Officer for Africa and the Middle East at the US National Institutes of Health; Science Attaché at the US Embassy in India; Associate Director for Health Equity in the Rockefeller Foundation; Senior Advisor on Research Strategy to the WHO; and Director of Child Health in the UBS Optimus Foundation in Zurich, Switzerland.
A seasoned leader in global health innovation, Dr. Gardner has served on the boards of the University of Michigan’s Center for Global Health, the Rockefeller Foundation’s pioneering impact investment fund (ProVenEx), and international non-profits. He currently serves on the board of a non-profit that promotes an innovative approach to water, sanitation and hygiene (WASH) training in low-income countries.
After completing his PhD, Dr. Gardner was awarded a Congressional Science Fellowship to advise the US Congress on health and science policy issues. He has also taught healthcare ethics as an Associate Professor at Howard University in Washington, D.C., and has over 90 publications.
Dr. Gardner is based in New York City. He holds a PhD in Developmental Neurobiology from the University of Michigan Medical School.
POSTS BY AUTHOR
The Foundation recently consulted with external experts from the fields of HIV and drug harm reduction to learn how they were able to tilt the needle away from moral panic, toward evidence-informed policies. Drawing on decades of experience, they told us that success requires a concerted effort to harness not just data, but emotion and […]
In the 1950s, if you asked a smoker why he or she smoked, they would not have replied, “because I am hopelessly addicted.” More likely, they would have told you about the pleasure they experienced from smoking. Today, we know something they did not. Smoking kills. Worldwide, 1.1 billion people smoke, causing more than 7 million deaths each year. […]
Years ago, at a global health research meeting, I remember one of the speakers complaining that researchers from high-income countries often “behave like a flock of seagulls” when working in low- and middle-income countries. She explained, “We have an ethical obligation not to fly in, collect the data, and then fly back out again, leaving […]
Small study; interesting findings. A new article published in Drug and Alcohol Review details how vaping (using e-cigarettes) helps some people avoid relapsing back to smoking. The authors, Caitlin Notley, Emma Ward, Lynne Dawkins, Richard Holland, and Sarah Jakes, have made a clear-headed and nuanced contribution to this controversial field. The paper is especially interesting to me because […]
The eighth session of the Conference of the Parties (COP8) to the World Health Organization (WHO) Framework Convention for Tobacco Control (FCTC) opened on Monday, October 1, 2018, in Geneva, Switzerland. This weeklong series of discussions will focus on global progress that has been made in the fight against tobacco. The FCTC, a treaty that has […]
Mission is to eliminate smoking worldwide by supporting cessation & harm reduction #research, and transitioning tobacco #farmers to alternative livelihoods.
In his latest blog, Derek Yach notes, “In 2020, we must not only acknowledge that smoking persists as a pressing global health threat, but also adapt our tactics to address the ways in which this threat has evolved.” #AccelerateTransformation http://bit.ly/37ci1ma
How insurers can profit while helping people to quit smoking
The Foundation is collaborating with the insurance industry to raise awareness about how insurers can help end smoking. This could create shared value that will benefit smokers, insurers and society as a whole. #endsmoking, #insuranceindustry. http://bit.ly/2sZCifK
David Janazzo, CFO and VP of #IndustryTransformation examines how Tobacco Free Portfolios, Bloomberg STOP’s Global Tobacco Industry Interference Index, and FSFW’s Tobacco Transformation Index are complementary. http://bit.ly/2QTQfoI
New ASH & Cancer Research UK report:
"Local authorities which do not currently provide e-cigarette starter packs as part of their cessation offer should consider doing so to give local smokers the best possible chance to quit."
"Only" 11% do so now.
Sign up with your email address to receive news and updates